Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -158.13% is 25% above its 5-year average of -212.21%, near the high end of its 5-year range (-981.31%–77.85%).
53.75% above its 12-month average of -341.92%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
-158.13%
OPERATING MARGIN AVG TTM
-341.92%
OPERATING MARGIN AVG 3Y
-373.25%
OPERATING MARGIN AVG 5Y
-212.21%
OPERATING MARGIN AVG 10Y
-279.35%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+53.75%
CURRENT VS 3Y AVG
+57.63%
CURRENT VS 5Y AVG
+25.48%
CURRENT VS 10Y AVG
+43.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-1161.28%
vs the sector median at left
Moderna, Inc.
Market Cap
$54.99B
Operating Margin
-158.13%
TTM Avg
-341.92%
3Y Avg
-373.25%
5Y Avg
-212.21%
Market Cap
$56.24B
Operating Margin
1.03%
TTM Avg
1.02%
3Y Avg
0.74%
5Y Avg
0.49%
Market Cap
$49.83B
Operating Margin
28.09%
TTM Avg
26.16%
3Y Avg
28.11%
5Y Avg
28.79%
Market Cap
$49.69B
Operating Margin
9.83%
TTM Avg
11.84%
3Y Avg
11.67%
5Y Avg
10.68%
Market Cap
$42.85B
Operating Margin
11.45%
TTM Avg
5.33%
3Y Avg
-0.33%
5Y Avg
-1.99%
Market Cap
$42.05B
Operating Margin
13.57%
TTM Avg
14.15%
3Y Avg
13.50%
5Y Avg
11.74%
Market Cap
$68.05B
Operating Margin
21.46%
TTM Avg
17.76%
3Y Avg
16.30%
5Y Avg
14.57%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $54.99B | -158.13% | -341.92% | -373.25% | -212.21% |
| Cardinal Health, Inc. (CAH)vs › | $56.24B | 1.03% | 1.02% | 0.74% | 0.49% |
| Edwards Lifesciences Corporation (EW)vs › | $49.83B | 28.09% | 26.16% | 28.11% | 28.79% |
| Becton, Dickinson and Company (BDX)vs › | $49.69B | 9.83% | 11.84% | 11.67% | 10.68% |
| Humana Inc. (HUM)vs › | $47.93B | 1.39% | 1.25% | 2.37% | 3.27% |
| Cencora, Inc. (COR)vs › | $63.11B | 1.30% | 1.08% | 1.06% | 1.09% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.85B | 11.45% | 5.33% | -0.33% | -1.99% |
| IQVIA Holdings Inc. (IQV)vs › | $42.05B | 13.57% | 14.15% | 13.50% | 11.74% |
| Boston Scientific Corporation (BSX)vs › | $68.05B | 21.46% | 17.76% | 16.30% | 14.57% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.06B | 32.03% | 30.27% | 29.30% | 28.64% |
Gross Margin
55.4%
Operating Margin
-158.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -562.07% |
| 2026-03-31 | -356.81% |
| 2025-12-31 | -126.40% |
| 2025-09-30 | -25.59% |
| 2025-06-30 | -638.73% |
| 2025-03-31 | -981.31% |
| 2024-12-31 | -130.33% |
| 2024-09-30 | -3.77% |
| 2024-06-30 | -616.74% |
| 2024-03-31 | -758.08% |
| 2023-12-31 | 0.21% |
| 2023-09-30 | -109.89% |
| 2023-06-30 | -542.73% |
| 2023-03-31 | -19.91% |
| 2022-12-31 | 30.69% |
| 2022-09-30 | 36.21% |
| 2022-06-30 | 53.59% |
| 2022-03-31 | 71.16% |
| 2021-12-31 | 77.85% |
| 2021-09-30 | 73.68% |
| 2021-06-30 | 72.65% |
| 2021-03-31 | 72.63% |
| 2020-12-31 | -48.19% |
| 2020-09-30 | -148.89% |
| 2020-06-30 | -184.06% |
| 2020-03-31 | -1559.92% |
| 2019-12-31 | -928.89% |
| 2019-09-30 | -767.12% |
| 2019-06-30 | -1098.44% |
| 2019-03-31 | -883.88% |
| 2018-12-31 | -432.03% |
| 2018-09-30 | -205.52% |
| 2018-06-30 | -336.26% |
| 2018-03-31 | -266.54% |
| 2017-12-31 | -45.51% |
| 2017-09-30 | -159.80% |
| 2017-06-30 | -223.46% |
| 2017-03-31 | -223.46% |
